Publications by authors named "John D Scandling"

Claim this Profile
C
Corrigendum: Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial.
Abdul Abdellatif, Lin Zhao, Katie Obermeyer, Zana Vranic, Brad A Marder, John D Scandling

Front Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial.
Abdul Abdellatif, Lin Zhao, Katie Obermeyer, Zana Vranic, Brad A Marder, John D Scandling

Front Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Medical Costs of Determining Eligibility and Waiting for a Kidney Transplantation.
Kunyao Xu, Avi Dor, Suman Mohanty, Jialin Han, Gomathy Parvathinathan, John D Scandling

Med Care· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open-label PROTECT clinical trial.
Abdul Abdellatif, Lin Zhao, Jason Chamberlain, Katya Cherny, Yan Xin, John D Scandling

Clin Transplant· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017.
Xingxing S Cheng, Jialin Han, Jennifer L Braggs-Gresham, Philip J Held, Stephan Busque, John D Scandling

JAMA Netw Open· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.
Thomas Fehr, Kerstin Hübel, Olivier de Rougemont, Irene Abela, Ariana Gaspert, John D Scandling

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients.
Aileen X Wang, Stephan Busque, Jamie Kuo, Upinder Singh, Katharina Röeltgen, John D Scandling

Kidney360· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The organ procurement costs of expanding deceased donor organ acceptance criteria: Evidence from a cost function model.
Xingxing S Cheng, Philip J Held, Avi Dor, Jennifer L Bragg-Gresham, Jane C Tan, John D Scandling

Am J Transplant· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients.
Kent P Jensen, David A Hongo, XuHuai Ji, PingPing Zheng, Rahul Pawar, John D Scandling

Blood Adv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Importance of Bringing Transplantation Tolerance to the Clinic.
A Benedict Cosimi, Nancy L Ascher, Jean C Emond, Dixon B Kaufman, Joren C Madsen, John D Scandling

Transplantation· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The center effect in kidney transplantation.
John D Scandling

Transpl Int· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The weekend effect and workforce in kidney transplantation.
John D Scandling

Transpl Int· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal.
Stephan Busque, John D Scandling, Robert Lowsky, Judith Shizuru, Kent Jensen

Sci Transl Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new approach to kidney wait-list management in the kidney allocation system era: Pilot implementation and evaluation.
Xingxing S Cheng, Stephan Busque, Jenny Lee, Kevin Discipulo, Christine Hartley, John D Scandling

Clin Transplant· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrochimerism and clinical transplant tolerance.
John D Scandling, Stephan Busque, Robert Lowsky, Judith Shizuru, Asha Shori

Hum Immunol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All's well following living kidney donation?
John D Scandling

Transpl Int· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals.
Bénédicte Sautenet, Allison Tong, Karine E Manera, Jeremy R Chapman, Anthony N Warrens, John D Scandling

Transplantation· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV infection is associated with lower survival in simultaneous liver kidney transplant recipients in the United States.
Ryan B Perumpail, Robert J Wong, John D Scandling, Le Dung Ha, Tsuyoshi Todo

Clin Transplant· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates and outcomes of warfarin initiation in kidney transplant recipients newly diagnosed with atrial fibrillation.
Colin R Lenihan, Maria E Montez-Rath, Jenny I Shen, John D Scandling, Mintu P Turakhia

Nephrol Dial Transplant· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Living donor evaluation and exclusion: the Stanford experience.
Jessica B Lapasia, Soo-yee Kong, Stephan Busque, John D Scandling, Glenn M Chertow

Clin Transplant· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induced immune tolerance for kidney transplantation.
John D Scandling, Stephan Busque, Judith A Shizuru, Edgar G Engleman, Samuel Strober

N Engl J Med· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
United network for organ sharing (UNOS) organ allocation policy and kidney utilization.
John D Scandling, Douglas J Norman

Am J Kidney Dis· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerance and chimerism after renal and hematopoietic-cell transplantation.
John D Scandling, Stephan Busque, Sussan Dejbakhsh-Jones, Claudia Benike, Maria T Millan

N Engl J Med· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired cystic kidney disease and renal cell cancer after transplantation: time to rethink screening?
John D Scandling

Clin J Am Soc Nephrol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rates of coronary artery stenosis detected by angiography in diabetic renal transplant candidates.
John D Scandling

Nat Clin Pract Nephrol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis